A chemoimmunotherapy regimen consisting of carboplatin, paclitaxel (Taxol) and bevacizumab used for the treatment of advanced-stage, nonsquamous non-small cell lung cancer. Or A chemotherapy combination used to treat endometrial, ovarian, and head and neck cancers, and non-small cell lung cancer that has spread. It includes the drugs carboplatin and paclitaxel (Taxol). Also called Carbo-Tax regimen, carboplatin-Taxol regimen, CaT regimen, and PC regimen.